Effect of recombinant human keratinocyte growth factor (Δ23rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation

International Journal of Radiation Biology

Volumn 86, Issue 10, 2010, Pages 860-866

  Jaal, Jana ^a   Richter, Caroline ^b   Dörr, Wolfgang ^b  

^a TARTU UNIVERSITY HOSPITAL   (Estonia)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

immune response; inflammation; irradiation; oral mucositis; Palifermin

Indexed keywords

ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; PALIFERMIN; ENDOGLIN PROTEIN, MOUSE; KERATINOCYTE GROWTH FACTOR; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; MACROPHAGE; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SINGLE DRUG DOSE; STAINING; TONGUE; VASODILATATION; ANIMAL; CELL COUNT; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; METABOLISM; RADIATION INJURIES, EXPERIMENTAL; RADIATION RESPONSE; STOMATITIS; VASCULARIZATION;

ANIMALIA; MUS;

ANIMALS; CELL COUNT; DOSE FRACTIONATION; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; RADIATION INJURIES, EXPERIMENTAL; RECOMBINANT PROTEINS; STOMATITIS; TONGUE; VASODILATION;

EID: 77957739599     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.487025     Document Type: Article

References (37)

1. Bonan PR, Kaminagakura E, Pires FR, Vargas PA, de Almeida OP. 2007. Histomorphometry and immunohistochemical features ofgrade I (WHO) oral radiomucositis. Oral Diseases 13:170-176.
2. Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W. 2008. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. Journal ofClinical Oncology 26:2489-2496.
3. Buell MG, Harding RK. 1989. Proinflammatory effects oflocal abdominal irradiation on rat gastrointestinal tract. Digestive Diseases and Sciences 34:390-399.
4. Dörr W, Bässler S, Reichel S, Spekl K. 2005a. Reduction of radiochemotherapy-induced early oral mucositis by recombi-nant human keratinocyte growth factor (palifermin): Experi-mental studies in mice. International Journal of Radiation Oncology Biology Physics 62:881-887.
5. Dörr W, Heider K, Spekl K. 2005b. Reduction of oral mucositis by palifermin (rHuKGF): Dose-effect of rHuKGF. Interna-tionalJournal of Radiation Biology 81:557-565.
6. DörrW, Reichel S, Spekl K. 2005c. Effects ofkeratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiotherapy Oncology 75:99-105.
7. Dörr W, Spekl K, Farrell CL. 2002. Amelioration of acute oral mucositis by keratinocyte growth factor: Fractionated irradia-tion. International Journal of Radiation Oncology Biology Physics 54:245-251.
8. Dörr W. 2003. Oral mucosa: Response modification by keratino-cyte growth factor. In: Nieder C, Milas L, Ang KK, editors. Biological modification of radiation response. Berlin-Heidel-berg-New York: Springer-Verlag. pp 113-122.
9. Dörr W. 2009. Pathogenesis of normal tissue side effects. In: Joiner M, Van der Kogel A, editors. Basic clinical radiobiology. 4th ed. London: HodderArnold. pp 169-190.
10. Elting LS, Cooksley CD, Chambers MS, Garden AS. 2007. Risk, outcomes, and costs ofradiation-induced oral mucositis among patients with head-and-neck malignancies. International Jour-nal of Radiation Oncology Biology Physics 68:1110-1120.
11. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M. 2008. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality oflife. Cancer 113:2704-2713.
12. Epperly MW, Sikora CA, DeFilippi SJ, Gretton JE, Bar-Sagi D, Archer H, Carlos T, Guo H, GreenbergerJS. 2002. Pulmonary irradiation-induced expression of VCAM-I and ICAM-I is decreased by manganese superoxide dismutase-plasmid/ lipo-some (MnSOD-PL) gene therapy. Biology of Blood and Marrow Transplantation 8:175-187.
13. Gillis P, Savla U, Volpert OV, Jimenez B, Waters CM, Panos RJ, Bouck NP. 1999. Keratinocyte growth factor induces angio-genesis and protects endothelial barrier function. Journal of Cell Science 112 (Pt 12):2049-2057.
14. Hallahan DE, Geng L, Shyr Y. 2002. Effects of intercellular adhesion molecule 1 (ICAM-1) null mutation on radiation-induced pulmonary fibrosis and respiratory insufficiency in mice. Journal ofthe National Cancer Institute 94:733-741.
15. Hallahan DE, Virudachalam S. 1997. Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Research 57:2096-2099.
16. Handschel J, Sunderkotter C, Prott FJ, Meyer U, Kruse-Losler B, Joos U. 2001. Increase of RM3/1-positive macrophages in radiation-induced oral mucositis. Journal ofPathology 193:242-247.
17. Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, Salzwimmer M, Whiley M, Emmerson L, Berger D. 2008. Palifermin significantly reduces severe oral mucositis in subjects with resected locally advanced head and neck cancer undergoing post-operative concurrent radio-chemotherapy. Radiotherapy Oncology 88(Suppl. 2):S152.
18. Ikeda Y, Ito M, Matsuu M, Shichijo K, Fukuda E, Nakayama T, Nakashima M, Naito S, Sekine I. 2000. Expression ofICAM-1 and acute inflammatory cell infiltration in the early phase of radiation colitis in rats. Journal of Radiation Research 41:279-291.
19. Jaal J, Dörr W. 2005. Early and long-term effects of radiation on intercellular adhesion molecule 1 (ICAM-1) expression in mouse urinary bladder endothelium. International Journal of Radiation Biology 81:387-395.
20. Jaal J, Dörr W. 2006. Radiation-induced inflammatory changes in the mouse bladder: The role of cyclooxygenase-2. Journal of Urology 175:1529-1533.
21. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE. 2007. Updated clinical practice guidelines for the prevention and treatment ofmucositis. Cancer 109:820-831.
22. Kyrkanides S, Olschowka JA, Williams JP, Hansen JT, O'Banion MK. 1999. TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interac-tion in CNS radiation injury. Journal of Neuroimmunology 95:95-106.
23. Lalla RV, Sonis ST, Peterson DE. 2008. Management of oral mucositis in patients who have cancer. Dental Clinics of North America 52:61-77.
24. Maeng HG, Kim DN, Cho SK, Cha JH, Kim TY, Lee YS, Choi DK, Lee JH, Cho MJ, Kwon HJ, Lee SK. 2006. Altered immune cell proportions in the radiodermatitis induced hairless mice-1 (HR-1). Journal of Radiation Research 47:9-17.
25. Martinez FO, Helming L, Gordon S. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annual Review ofImmunology 27:451-483.
26. Narayan K, Cliff WJ. 1982. Morphology of irradiated micro-vasculature: A combined in vivo and electron-microscopic study. American Journal ofPathology 106:47-62.
27. Olschowka JA, Kyrkanides S, Harvey BK, O'Banion MK, Williams JP, Rubin P, Hansen JT. 1997. ICAM-1 induction in the mouse CNS following irradiation. Brain Behavior and Immunity 11:273-285.
28. Panes J, Anderson DC, Miyasaka M, Granger DN. 1995. Role of leukocyte-endothelial cell adhesion in radiation-induced microvascular dysfunction in rats. Gastroenterology 108:1761-1769.
29. Roebuck KA, Finnegan A. 1999. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. Journal of Leukocyte Biology 66:876-888.
30. Rosenthal DI, Trotti A. 2009. Strategies for managing radiationinduced mucositis in head and neck cancer. Seminars in Radiation Oncology 19:29-34.
31. Russo G, Haddad R, Posner M, Machtay M. 2008. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13:886-898.
32. Song CW, Kim JH, Rhee JG, Levitt SH. 1983. Effect of X irradiation and hyperthermia on vascular function in skin and muscle. Radiation Research 94:404-415.
33. Sonis ST. 2007. Pathobiology of oral mucositis: Novel insights and opportunities. Journal ofSupportive Oncology 5:3-11.
34. Treister N, Sonis S. 2007. Mucositis: Biology and management. Current Opinion in Otolaryngology, Head and Neck Surgery 15:123-129.
35. Vera-Llonch M, Oster G, Hagiwara M, Sonis S. 2006. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329-336.
36. Yuan H, Gaber MW, McColgan T, Naimark MD, Kiani MF, Merchant TE. 2003. Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: Modulation with anti-ICAM-1 antibodies. Brain Research 969:59-69.
37. Zhang X, Mosser DM. 2008. Macrophage activation by endogenous danger signals. Journal ofPathology 214:161-178.